Paul Edward Gross Clovis Oncology, Inc. (CLVS) insider trading activity

Paul Edward Gross is Officer of Clovis Oncology, Inc.. Currently has a direct ownership of 98,330 shares of CLVS, which is worth approximately $8,849. The most recent transaction as insider was on Nov 02, 2022, when has been sold 4,730 shares (Common Stock) at a price of $0.98 per share, resulting in proceeds of $4,635. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 98.3K

0% 3M change

0% 12M change

Total Value Held $8,849

Paul Edward Gross Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 02 2022	SELL Open market or private sale	$4,635 $0.98 p/Share	4,730 Reduced 4.59%	98,330 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	-	10,248 Added 9.26%	100,465 Common Stock
Sep 02 2022	SELL Open market or private sale	$2,770 $1.2 p/Share	2,308 Reduced 2.43%	92,812 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	5,063 Added 5.05%	95,120 Common Stock
Aug 02 2022	SELL Open market or private sale	$7,018 $1.46 p/Share	4,807 Reduced 5.07%	90,057 Common Stock
Aug 01 2022	BUY Exercise of conversion of derivative security	-	10,249 Added 10.0%	92,226 Common Stock
Jun 02 2022	SELL Open market or private sale	$1,538 $0.64 p/Share	2,403 Reduced 2.76%	84,615 Common Stock
Jun 01 2022	BUY Exercise of conversion of derivative security	-	5,062 Added 5.5%	87,018 Common Stock
May 02 2022	SELL Open market or private sale	$9,003 $1.97 p/Share	4,570 Reduced 5.28%	81,956 Common Stock
May 01 2022	BUY Exercise of conversion of derivative security	-	10,248 Added 10.87%	84,018 Common Stock
Mar 02 2022	SELL Open market or private sale	$20,020 $1.87 p/Share	10,706 Reduced 12.31%	76,278 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	20,813 Added 19.36%	86,694 Common Stock
Feb 02 2022	SELL Open market or private sale	$10,546 $1.94 p/Share	5,436 Reduced 7.59%	66,171 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	-	10,250 Added 13.0%	68,624 Common Stock
Dec 02 2021	SELL Open market or private sale	$744 $3.0 p/Share	248 Reduced 0.4%	61,357 Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	-	562 Added 0.9%	61,605 Common Stock
Nov 02 2021	SELL Open market or private sale	$20,580 $4.55 p/Share	4,523 Reduced 6.9%	61,043 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	-	10,248 Added 13.97%	63,084 Common Stock
Sep 02 2021	SELL Open market or private sale	$1,218 $4.89 p/Share	249 Reduced 0.45%	55,318 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	-	563 Added 1.0%	55,567 Common Stock
Aug 03 2021	SELL Open market or private sale	$21,724 $4.82 p/Share	4,507 Reduced 7.57%	55,004 Common Stock
Aug 01 2021	BUY Exercise of conversion of derivative security	-	10,249 Added 15.23%	57,038 Common Stock
Jun 03 2021	SELL Open market or private sale	$1,301 $5.63 p/Share	231 Reduced 0.47%	49,262 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	-	562 Added 1.12%	49,493 Common Stock
May 04 2021	SELL Open market or private sale	$26,803 $5.54 p/Share	4,838 Reduced 9.0%	48,931 Common Stock

PEG

Paul Edward Gross

Officer

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLVS shares.

Notify only if

Value

Insider Trading

Get notified when an Clovis Oncology, Inc. insider buys or sells CLVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Clovis Oncology, Inc.

Track Activities on CLVS

Account